2024
Challenges and recent advances in erythropoietin stability
Search citation statements
Paper Sections
Select...
8
0
0
0
Citation Types
0
2
0
0
Year Published
Range
2025
2026
Publication Types
Select...
8
Relationship
0
8
Authors
Journals
Cited by 8 publications
(2 citation statements)
References 149 publications
0
2
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…The optimization of carrier materials, encapsulation techniques, and sterilization methods are necessary to ensure prolonged bioactivity without compromising scaffold integrity. The long-term stability of EPO-loaded scaffolds, while demonstrated in preclinical settings ( Fayed et al, 2024 ), lacks human trial validation, raising concerns about polymer degradation kinetics and sustained bioactivity beyond 6 months. Safety risks remain paramount: systemic EPO use increases thromboembolism and stroke risks ( Ma et al, 2022 ; Åberg et al, 2016 ; Lippi Massimo and Favaloro Emmanuel, 2010 ; Anaissie et al, 2012 ).…”
Section: Conclusion and Future Prospects
mentioning
confidence: 99%
Abstract